FDA — authorised 18 December 2019
- Application: NDA211882
- Marketing authorisation holder: BAUSCH
- Local brand name: ARAZLO
- Indication: LOTION — TOPICAL
- Status: approved
🇺🇸 Tazarotene 0.045% Lotion in United States
FDA authorised Tazarotene 0.045% Lotion on 18 December 2019
Marketing authorisation
Other Dermatology approved in United States
Frequently asked questions
Is Tazarotene 0.045% Lotion approved in United States?
Yes. FDA authorised it on 18 December 2019.
Who is the marketing authorisation holder for Tazarotene 0.045% Lotion in United States?
BAUSCH holds the US marketing authorisation.